Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Downgrade Victorias Secret Amidst Negative Developments

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
DrugRetailers Stock Bull Market
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, analyst Alice Xiao from B of A Securities made the decision to downgrade Victoria’s Secret (NYSE:VSCO) from Buy to Underperform. She also decreased the price target from $34 to $15. This downgrade comes amidst a series of negative developments for Victoria’s Secret, including a drop in share value following Wells Fargo & Company’s decision to lower the price target on the stock. JPMorgan has also joined in on the pessimism, downgrading Victoria’s Secret to Underweight and setting a price target of $15.00. It appears that the consensus among analysts is that Victoria’s Secret is encountering significant challenges, as multiple firms are revising their ratings and price targets downward.

VSCO Stock Plummets 29.70% Amid Concerns About Companys Future Prospects

On March 8, 2024, VSCO stock experienced a significant drop in its price momentum, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock closed at $18.01, marking a decrease of $7.61 since the market last closed, representing a 29.70% drop.

Investors and analysts are closely monitoring the performance of VSCO stock as it continues to face challenges in the market. The drop in price momentum has raised concerns among shareholders about the company’s financial health and future prospects.

In pre-market trading on March 8, 2024, VSCO stock continued to decline, dropping an additional $0.06. This downward trend has sparked speculation about the factors contributing to the stock’s poor performance and whether the company will be able to rebound in the near future.

VSCO Stock Performance Analysis: Revenue Holds Flat, EPS Sees Impressive Increase

VSCO, the popular photo editing and sharing app, has been making headlines recently with its stock performances on March 8, 2024. According to data from CNN Money, the company reported total revenue of $6.18 billion for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the last quarter was $2.08 billion, also holding flat since the previous quarter.

While the total revenue figures may not show significant growth, VSCO did see some fluctuations in its net income and earnings per share (EPS) numbers. The net income for the past year was reported at $109.20 million, a decrease of 68.62% compared to the previous year. However, the net income for the last quarter was $181.09 million, holding flat compared to the previous quarter.

In terms of EPS, VSCO reported $1.39 for the past year, showing a decrease of 66.45% compared to the previous year. However, the EPS for the last quarter was $2.29, indicating an impressive increase of 348.88% compared to the previous quarter.

These numbers suggest that VSCO has been able to maintain its revenue levels while seeing fluctuations in its net income and EPS figures. The increase in EPS for the last quarter could be a positive sign for investors, indicating potential growth in the future.

Investors should conduct thorough research and analysis before making any investment decisions. Overall, VSCO’s stock performances on March 8, 2024, show a mixed picture with some positive indicators in terms of EPS growth, despite fluctuations in net income. It will be interesting to see how the company continues to perform in the coming months and whether it can sustain its growth trajectory.

Tags: VSCO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Cash

UBS Analyst Downgrades Maxeon Solar Technologies Ltd from Neutral to Sell

Food Retailers Stock Bull Market

Analyst Perspectives on BJs Wholesale Club A Mixed Bag of Opinions

Finance_Assets (3)

CNBC Experts Share Final Trades for March 8 2024

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com